
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Renal Cell Carcinoma With Bone Metastases: RADICAL (Alliance A031801).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 27, 2026
Prostate Cancer Biomarkers with a Focus on Galectin-3: Emerging Clinical and Therapeutic Implications.
Journal: Current oncology (Toronto, Ont.)
Published: March 09, 2026
Impact of SPOP Mutations on Clinical Outcomes in Metastatic Prostate Cancer.
Journal: JCO precision oncology
Published: December 05, 2025
Real-World Outcomes of Patients With Baseline Neuropathy and/or Diabetes Mellitus Receiving Enfortumab Vedotin-Based Regimens for Advanced Urothelial Carcinoma in the UNITE Database.
Journal: Clinical genitourinary cancer
Published: December 02, 2025
Association between smoking, tumor genetics, and outcomes in men with metastatic prostate cancer.
Journal: Prostate cancer and prostatic diseases
Published: December 02, 2025
CHIMERA-DDR: A Machine Learning Framework for Classifying Heterogeneous Mismatch-Repair and Homologous-Recombination Deficiency Patterns in Prostate Cancer.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
Molecular Characterization of KLK2 RNA Expression in Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 12, 2025
Study design and methodologies for the men moving forward lifestyle intervention trial with black prostate cancer survivors.
Journal: Contemporary clinical trials
Published: August 12, 2025
Genomic alterations and associated outcomes in patients with PSMA-positive metastatic castration-resistant prostate cancer treated with 177Lu-PSMA-617.
Journal: The oncologist
Published: June 27, 2025
Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study.
Journal: The oncologist
Published: June 09, 2025
Last Updated: 09/26/2026